GTN Company
GTN innovates a quantum machine learning technology to transform drug discovery.
Investors
Technology:
Small Molecules
Industry:
AI in Pharma, Early Drug Development
Headquarters:
London, England, United Kingdom
Founded Date:
2017-05-17
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
6
Total Funding:
2100000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-11-01
Last Funding Type:
Seed
Register and Claim Ownership